|
Showing 1 - 1 of
1 matches in All Departments
Animal cell technology has undergone a rapid transformation over
the last decade from a research tool and highly specialised
technology to a central resource for innovation in pharmaceutical
research and development. These proceedings of the 14th Meeting of
the European Society for Animal Cell Technology (Vilamoura,
Portugal, May 1996) bring up to date the historical perspective of
animal cell technology for the benefit of society, `From Vaccines
to Genetic Medicine', and will charter this vital technology for
the years to come. Strong contributions are grouped in the
traditional ESACT areas of 'Cell and Physiology Engineering'
dealing with cell state, including genetics, and its environment,
and 'Animal Cell Process Engineering' covering integration of
bioreaction with bioseparation coupled with on-line monitoring to
improve protein production and consistency. Extensive coverage of
metabolic engineering on synthesis, folding, assembly, transiting
and secretion is dealt with in the session on 'Recombinant
Proteins: Biosynthesis and Bioprocessing'. Two traditional but
expanding areas of animal cell technology relevance are highlighted
in the broad sessions of 'Animal Cells as Tools for Discovery and
Testing' and 'Animal Cell Vaccines: Present and Future'. Two
sessions finally cover the more recent domains of animal cell
technology work - 'Tissue Engineering and Biomedical Devices' and
'Cells and Vectors for Genetic Medicine' - where one can foresee a
very bright future.
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.